Biogen International GmbH

Swiss Biotech Association

Member
Claim / update listing

At Biogen, we develop, market and manufacture therapies for people living with serious neurological, autoimmune and rare diseases.

http://www.biogen-international.com

Location

Neuhofstrasse 30, 6340 Baar, Switzerland

Facts & figures

Type of organization

Public company
Number of employees in Switzerland

>250

Key business

Core competencies

Therapeutics/vaccines (human)

You may also be interested in

Limula SA

Limula SA is developing a platform technology to enable scale out of cell therapy manufacturing, directly at the point of care. We support companies at all stages of the life cycle of their therapies, from R&D to routine production.
La Tour-de-Peilz

Laevoroc Oncology AG

Founded in 2019, Laevoroc is a privately-owned, Swiss oncology group of companies that leverages word-class technologies, our oncology expertise and extensive R&D and commercial experience to approach innovation in cancer therapeutics in a way that combines the pragmatic with the visionary.
Hünenberg

Rowestil Consulting GmbH

Expertise in exploratory clinical drug/diagnostic development is available across a number of disease areas. Timing of input into the developmental strategy from regulatory and commercial perspectives is important in moving development programs towards success.
6318 Walchwil